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Special AT-rich sequence binding protein 1 (SATB1) is a 
nuclear matrix-associated DNA-binding protein that functions 
as a chromatin organizer. SATB1 is highly expressed in 
aggressive breast cancer cells and promotes growth and 
metastasis by reprograming gene expression. Through genome- 
wide cross-examination of gene expression and histone 
methylation, we identified SATB1 target genes for which 
expression is associated with altered epigenetic marks. Among 
the identified genes, long noncoding RNA urothelial 
carcinoma-associated 1 (UCA1) was upregulated by SATB1 
depletion. Upregulation of UCA1 coincided with increased 
H3K4 trimethylation (H3K4me3) levels and decreased H3K27 
trimethylation (H3K27me3) levels. Our study showed that 
SATB1 binds to the upstream region of UCA1 in vivo, and that 
its promoter activity increases with SATB1 depletion. 
Furthermore, simultaneous depletion of SATB1 and UCA1 
potentiated suppression of tumor growth and cell survival. 
Thus, SATB1 repressed the expression of oncogenic UCA1, 
suppressing growth and survival of breast cancer cells. [BMB 
Reports 2016; 49(10): 578-583]
INTRODUCTION
Breast cancer is the most frequently diagnosed life-threatening 
cancer in women and the leading cause of cancer death in 
American women after lung cancer (1). Formation and 
progression of breast cancer is driven by epigenetic alterations 
as well as progressive genetic abnormalities (2). Epigenetic 
alterations involve aberrations such as DNA methylation, 
histone modifications, and nucleosome remodeling. These 
epigenetic events modulate chromatin structure, which in turn 
causes aberrant transcriptional regulation that results in 
changes in the expression patterns of genes implicated in 
cellular proliferation, survival, and differentiation (3). Among 
epigenetic alterations, histone modifications play a funda-
mental role in carcinogenesis; recent advances in epigenomic 
analyses show that patterns of histone marks are profoundly 
altered in cancer cells (3).
Special AT-rich sequence binding protein 1 (SATB1) is a 
nuclear matrix-associated protein that binds to the ATC-rich 
DNA sequences of base unpairing regions (BURs) (4). Struc-
turally, SATB1 consists of an N-terminal PDZ-like domain, a 
C-terminal homeodomain, and tandem CUT domains in the 
center (5). The PDZ-like domain contributes to the DNA- 
binding ability of SATB1 through oligomerization and 
modulates the association of SATB1 with other proteins via 
post-translational modifications. The CUT domains and the 
homeodomain mediate the sequence-specific binding of 
SATB1 to its DNA targets. Through BUR-binding, SATB1 
tethers multiple genomic loci to the nuclear matrix to build the 
appropriate higher-order chromatin structure (6, 7). In addition, 
SATB1 recruits various transcription factors and chromatin 
modifying enzymes to regulate gene expression through histone 
modifications and nucleosomal remodeling at SATB1-bound 
matrix-associated regions (8). Therefore, SATB1 functions as a 
chromatin organizer that integrates global epigenetic and 
transcriptional programs, which are essential for cellular 
phenotypes and differentiation.
By controlling the expression of transcription factors such as 
GATA binding protein 3 (GATA3), Sfpi1, or Nanog, SATB1 
functions in thymocyte development, T helper type 2 lineage 
commitment of naïve T cells, and embryonic stem cell 
differentiation (9, 10). Interestingly, high expression levels of 
SATB1 in metastatic breast cancer cells and in aggressive and 
poorly differentiated breast cancer tissues, as well as non- 
expression (or non-detection) in normal adjacent tissues, 
suggest that SATB1 has a role in the metastatic phenotype of 
breast cancer cells (11). Depletion of SATB1 in aggressive 
breast cancer cells reverses the metastatic potential, whereas 
ectopic expression of SATB1 in non-aggressive cells induces 
metastatic and tumorigenic activities (11). These findings 
strongly suggest that SATB1 can function as a determinant of 
breast cancer metastasis. Moreover, a Kaplan-Meier survival 
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Fig. 1. Genome-wide changes in gene expression and histone 
methylation induced by SATB1 depletion. MDA-MB-231 cells were
infected with lentiviruses expressing shRNA against SATB1 or con-
taining empty pLKO.1 vector; drug-resistant cells were selected. 
(A) Scatter plot shows differentially expressed genes from control 
shRNA (CTL) and SATB1 shRNA (KD) cells. Significantly changed 
genes (fold change ＞ 2, P value ＜ 0.05) that are upregulated in 
SATB1 shRNA cells (red) or downregulated in SATB1 shRNA cells 
(green) are indicated. (B and C) Scatter plots show genes with 
differential enrichment of H3K4me3 (B) and H3K27me3 (C) 
within the promoter region (3 kb either side of the TSS) for 
control shRNA (CTL) and SATB1 shRNA (KD) cells. Significantly 
changed genes (fold change ＞ 1.5, P value ＜ 0.05) that are up-
regulated in SATB1 shRNA cells (red) or downregulated in SATB1
shRNA cells (green) are indicated. (D) Venn diagram shows overlap
of SATB1 knockdown-induced genes that were upregulated in 
RNA expression, had greater H3K4me3 enrichment at the promoter
region, and had lesser H3K27me3 enrichment at the promoter 
region. (E) Venn diagram shows overlap of SATB1 knockdown- 
induced genes that were downregulated in RNA expression, had 
lesser enrichment with H3K4me3 at the promoter region, and had 
greater enrichment with H3K27me3 at the promoter region.
analysis revealed a correlation between high expression levels 
of SATB1 with shorter survival rates in breast cancer patients, 
and a multivariate analysis confirmed that SATB1 is an 
independent prognostic marker in patients (12). Additional 
studies have associated SATB1 with the development of 
various cancers, including bladder, colorectal, gastric, liver, 
ovarian, pancreatic, and prostate cancer (13). 
Although alterations in SATB1 expression are shown to 
disrupt the pattern and levels of histone acetylation, which 
promote tumor growth and metastasis through deregulation of 
gene expression (11), the effect of SATB1 on chromatin 
structure in a genome-wide scale, and its correlation with gene 
expression profiles have not been explored in breast cancer 
cells. In this study, we used chromatin immunoprecipitation- 
coupled to deep sequencing (ChIP-seq) to profile genome- 
wide locations of H3K4 trimethylation (H3K4me3) and H3K27 
trimethylation (H3K27me3) epigenetic marks in MDA-MB-231 
aggressive breast cells. Furthermore, we identified a list of 
SATB1 target genes that showed significant alterations on these 
histone modifications after SATB1 depletion and examined 
their correlation with gene expression. Among the identified 
genes, we revealed that long noncoding RNA urothelial 
carcinoma-associated 1 (UCA1) was upregulated by SATB1 
depletion and regulated via an epigenetic mechanism to 
control growth and apoptosis of aggressive breast cancer cells.
RESULTS 
Genome-wide changes in H3K4me3 and H3K27me3 levels 
by SATB1 depletion
To investigate the role of SATB1 in tumor growth and 
metastasis in MDA-MB-231 breast cancer cells, we knocked 
down SATB1 expression by using lentiviral vector-mediated 
RNA interference of SATB1. Depletion of SATB1 in SATB1 
short hairpin RNA (shRNA) (KD) cells was validated at 
messenger RNA (mRNA) and protein levels (Fig. S1A and S1B). 
We performed mRNA sequencing (mRNA-seq) using the 
SATB1-knockdown system and identified genes with significant 
change in expression levels (fold change ＞ 2, P value ＜ 0.05) 
(Fig. 1A). Differentially expressed genes (DEG) included 222 
downregulated genes and 470 upregulated genes. To validate 
mRNA-seq data, we measured several altered genes by 
quantitative real-time polymerase chain reaction (qRT-PCR) 
(Fig. S1C). To assess whether SATB1 can affect genome-wide 
distribution of histone modification, we performed ChIP-seq 
using antibodies against H3K4me3, which is present in 
promoters of actively transcribed genes, and against H3K27me3, 
which is associated with the repression of transcription. 
ChIP-seq profiles in both control shRNA (CTL) and SATB1 
shRNA (KD) cells revealed thousands of discrete genomic 
regions that are enriched with either H3K4me3 or H3K27me3 
marks. Consistent with a previous report (14), genomic regions 
with H3K4me3 or H3K27me3 modifications were identified 
preferentially at promoter or intergenic regions, respectively 
(Fig. S2A). 
The proximal sequences around the transcription start site 
(TSS) are essential elements of gene regulation (15). Therefore, 
we examined uniquely mapped tags of H3K4me3 and 
H3K27me3 at promoter regions, which were defined in this 
study as 3.0 kb upstream and downstream of the TSS (± 3.0 
kb around the TSS). According to the estimation provided by 
mRNA-seq analysis, highly transcribed genes exhibited high 
H3K4me3 levels but very low H3K27me3 levels around the 
TSS. In contrast, silent genes were depleted of H3K4me3 
marks and exhibited high levels of H3K27me3 (Fig. S2B and 
S2C). These results confirmed the positive correlation between 
transcription activity and H3K4me3 levels at promoter regions, 
and the negative correlation between transcription activity and 
H3K27me3 levels at promoter regions. To investigate potential 
changes in H3K4me3 and H3K27me3 levels caused by SATB1 
depletion, we compared genome-wide enrichment of H3K4me3 
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Fig. 2. Upregulation of UCA1 induced by SATB1 depletion 
coincides with altered histone methylation. (A) Genomic snapshot 
of the UCA1 locus. Density of mRNA-seq reads and ChIP-seq 
reads of H3K4me3 and H3K27me3 in control shRNA (CTL) and 
SATB1 shRNA (KD) cells are shown. (B) qRT-PCR validation of 
UCA1 expression in control shRNA (CTL) and SATB1 shRNA (KD) 
cells (mean ± standard error of the mean [SEM] of three in-
dependent biological replicates) (C-F) ChIP-qPCR validation of 
H3K4me3 (C), H3K27me3 (D), H3K27Ac (E), and EZH2 (F) levels 
at the UCA1 locus. 
Fig. 3. Direct regulation of UCA1 by SATB1. (A) Genomic 
snapshot of the UCA1 locus showing ChIP-seq reads for SATB1 in 
MDA-MB-231 cells. (B) ChIP-qPCR validation for SATB1 binding 
at the UCA1 locus in control shRNA (CTL) and SATB1 shRNA 
(KD) cells. (C) Luciferase constructs containing UCA1 promoter 
with or without 3.0-kb upstream region were transfected into 
control shRNA (CTL) and SATB1 shRNA (KD) cells. Values are 
mean ± SEM of results from three experiments.
and H3K27me3 at gene promoter regions for control shRNA 
(CTL) and SATB1 shRNA (KD) cells. By using the edgeR 
(empirical analysis of digital gene expression data in R) 
approach, we identified 2,975 and 1,408 gene promoter 
regions with differentially higher and lower levels (fold change 
＞ 1.5), respectively, of H3K4me3 in SATB1-knockdown cells 
(Fig. 1B). We also identified 5,327 and 1,384 gene promoter 
regions with differentially higher and lower levels of 
H3K27me3 in SATB1-knockdown cells (fold change ＞ 1.5), 
respectively. (Fig. 1C). Next, we focused on DEGs to identify 
SATB1 target genes for which expressions are regulated by 
altered histone methylation. Among the 222 genes upregulated 
by SATB1 depletion, we identified 33 genes with higher 
H3K4me3 levels, 39 genes with lower H3K27me3 levels, and 
6 genes with both higher H3K4me3 and lower H3K27me3 
levels (Fig. 1D, Table S2). Among the 470 genes downregulated 
by SATB1 depletion, we found 99 genes with lower H3K4me3 
levels, 179 genes with higher H3K27me3 levels, and 45 genes 
with both lower H3K4me3 and higher H3K27me3 levels (Fig. 
1E, Table S3).
Repression of long noncoding RNA UCA1 by SATB1
We identified long noncoding RNA (lncRNA) urothelial 
carcinoma-associated 1 (UCA1) as one of the epigenetically 
regulated SATB1 target genes (Fig. 2A). UCA1 was originally 
identified in bladder transitional cell carcinoma (16) and is 
known to play an important role in the occurrence and 
development of many tumor and non-tumor diseases (17). 
Integration of mRNA-seq and ChIP-seq demonstrated that 
upregulation of UCA1 lncRNA after SATB1 depletion coincided 
with an increased level of H3K4me3 and a decreased level of 
H3K27me3 at the promoter (Fig. 2A). These results were 
validated independently by performing qRT-PCR (Fig. 2B) and 
ChIP-qPCR (Fig. 2C and 2D). An increased level of H3K27 
acetylation (H3K27Ac), another active gene regulatory histone 
modification marker, at UCA1 promoter region was also 
increased by SATB1 depletion (Fig. 2E). However, the enrichment 
of Ezh2, which catalyzes trimethylation of H3K27, was not 
changed at the UCA1 promoter region (Fig. 2F).
To further understand the molecular basis of SATB1-mediated 
UCA1 repression, we examined whether UCA1 is directly 
regulated by SATB1. Analysis of ChIP-seq data against SATB1 
(unpublished data from our laboratory) revealed prominent 
SATB1 binding to the promoter and the 3.0-kb upstream 
region of UCA1 (Fig. 3A). Binding of SATB1 to these regions 
was independently validated by performing ChIP-qPCR (Fig. 
3B). Furthermore, SATB1 depletion abrogated the enrichment 
of SATB1 on the UCA1 locus, further confirming the validity of 
the ChIP-seq data (Fig. 3B). To test whether the promoter and 
the 3.0-kb upstream region of UCA1 contain SATB1 response 
elements, the regions were separately subcloned into a 
luciferase reporter construct. Transfection of these luciferase 
constructs into MDA-MB-231 cells revealed a significant 
increase of promoter activities by SATB1 depletion (Fig. 3C). 
The data indicated that SATB1 represses UCA1 expression by 
directly binding to the UCA1 promoter and 3.0-kb upstream 
regions. 
In contrast to the findings for SATB1-mediated UCA1 
repression, SATB1 expression remained unaltered in MDA- 
MB-231 cells expressing shRNA against UCA1, which suggests 
that SATB1 is the upstream regulator of UCA1 expression (Fig. 
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Fig. 4. Effect of SATB1 and UCA1 on breast cancer cell growth 
and apoptosis. MDA-MB-231 cells were infected with lentiviruses 
expressing shRNA against SATB1 or UCA1; drug-resistant cells were
selected. (A) qRT-PCR was performed to analyze mRNA levels of 
SATB1 and UCA1 and normalized against 18S ribosomal RNA 
(rRNA) levels. (B) Viable cells were counted by Trypan blue 
staining after depletion of SATB1 and/or UCA1. (C) Flow cytometric
analysis of apoptotic cells induced by depletion of SATB1 and/or 
UCA1. For each sample, the bar indicates standard deviation (SD) 
from three experiments.
4A). MDA-MB-231 cells simultaneously infected with lentiviruses 
expressing shRNA against SATB1 and UCA1, showed a 
significant decrease of expression for both genes (Fig. 4A). In 
agreement with previous reports (11, 18), depletion of either 
SATB1 or UCA1 suppressed the growth of MDA-MB-231 cells 
(Fig. 4B), which supports the oncogenic roles of both genes. 
Interestingly, cell viability was nearly abrogated by simultaneous 
depletion of SATB1 and UCA1 (Fig. 4B). In addition, we 
analyzed apoptosis of MDA-MB-231 cells after knockdown of 
SATB1 or UCA1 expression. Depletion of either SATB1 or 
UCA1 triggered significant apoptosis of MDA-MB-231 cells, 
and simultaneous depletion of both genes further increased 
apoptosis (Fig. 4C). The data indicated that SATB1 depletion 
results in upregulation of oncogenic lncRNA UCA1, which 
promotes growth and survival of MDA-MB-231 breast cancer 
cells.
DISCUSSION 
SATB1 is a global chromatin organizer that integrates higher- 
order chromatin architecture with regulation of gene ex-
pression and modulates the accessibility of many gene loci to 
chromatin remodeling enzymes and transcription factors. 
Several studies have demonstrated the critical role of SATB1 in 
cancer in which enhanced expression of SATB1 promotes 
aberrant growth and metastasis of various epithelial tumors by 
reprogramming global transcriptional profiles. In this study, we 
investigated the effect of SATB1 on histone modification status 
in a genome-wide scale to better understand its epigenetic 
mechanism in breast cancer. Two histone methylation marks, 
activating H3K4me3 and silencing H3K27me3, were analyzed 
by ChIP-seq. We focused on the promoter regions for the 
enrichment of these epigenetic marks, and thousands of genes 
were found to have differential levels of H3K4me3 and 
H3K27me3 after SATB1 depletion. These changes in H3K4me3 
and H3K27me3 levels support the suggested role of SATB1 as 
a global chromatin organizer and epigenetic factor. By in-
tegrating chromatin modification (ChIP-seq) with gene expression 
(mRNA-seq), we identified SATB1 target genes for which 
expression is associated with histone modifications. Depletion 
of SATB1 led to upregulation of genes that coincided with 
higher H3K4me3 levels and lower H3K27me3 levels at 
promoter regions. In addition, SATB1 depletion resulted in 
downregulation of genes for which expression was associated 
with lower H3K4me3 levels and higher H3K27me3 levels. 
However, many genes differentially expressed by SATB1 
depletion did not show significantly altered histone modifications 
at their promoters. SATB1 may regulate the expression of these 
genes by modulating chromatin structure at distal regulatory 
elements other than the promoter region, or by mediating 
long-range chromatin interaction between such regulatory 
elements and their cognate promoters.
Here, we revealed that UCA1 is a novel SATB1 target gene, 
which is regulated via an epigenetic mechanism in aggressive 
breast cancer cells. UCA1 is an lncRNA that is aberrantly 
expressed in a broad range of cancers and plays oncogenic 
roles in tumor growth and metastasis. Recent studies show that 
UCA1 expression can be upregulated by several transcription 
factors, including Ets-2, C/EBP, and HIF-1 (19-21). In addition, 
transforming growth factor beta (TGF-) treatment of breast 
cancer cells is reported to induce UCA1 expression by 
recruiting a transcriptional complex composed of TAZ, YAP, 
TEAD and SMAD2/3 (22). In contrast, repression of UCA1 
expression is mediated in human foreskin fibroblasts by 
CAPER/ TBX3 transcriptional complex (23). 
Previous studies have focused on the role of SATB1 in 
mRNA expression but its role in lncRNA transcription has not 
been studied. This study seems to be the first report describing 
the function of SATB1 in lncRNA transcription. In addition to 
UCA1, RNA-seq analysis revealed that expression of other 
lncRNAs, such as HCP5 and LOC100506844, are positively 
regulated by SATB1. Further studies will be necessary to 
dissect how these lncRNAs are regulated by SATB1. 
Upregulation of UCA1 after SATB1 depletion coincided with 
increased levels of activating histone marks, H3K4me3 and 
H3K27Ac, and a decreased level of repressive H3K27me3 at 
the promoter. This result suggests that SATB1 represses UCA1 
expression by closing the chromatin structure at the promoter 
region of UCA1. ChIP assay showed in vivo occupancy of 
SATB1 at the promoter and 3.0-kb upstream regions of UCA1. 
Moreover, transient transfection experiments using luciferase 
reporter constructs confirmed the repressive activity of these 
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SATB1 binding sites. Because enrichment of the histone 
methyltransferase EZH2 at the UCA1 promoter region was not 
affected by SATB1 depletion, the change in H3K27me3 level 
at the promoter may not be dependent on EZH2. H3K27 
demethylases UTX and JMJD3 has been discovered to actively 
demethylate H3K27me3 (24), and UTX has been shown to be 
part of the H3K4me3 methyltransferase complex (25). Whether 
SATB1 can affect the recruitment of these H3K27 demethylases 
and H3K4me3 methyltransferase complex to the UCA1 locus 
remains to be elucidated.
The role of UCA1 in cell proliferation and apoptosis has 
been studied in various cancers. In breast cancer cells, UCA1 
interacts with heterogeneous nuclear ribonucleoprotein I 
(hnRNP I) and suppresses p27 protein expression, leading to 
increased cell proliferation (18). In addition, UCA1 interacts 
directly with miR-143 and modulates breast cancer cell growth 
and apoptosis (26). Consistent with those reports, our study 
indicated that depletion of UCA1 results in attenuated growth 
and induced apoptosis in MDA-MB-231 cells. Depletion of 
SATB1 resulted in induced UCA1 expression, and simultaneous 
depletion of SATB1 and UCA1 potentiated the suppression of 
growth and survival of breast cancer cells. These effects indicate 
that upregulated UCA1 may partially rescue the growth and 
survival of SATB1-knockdown MDA-MB-231 cells. Our results 
strongly suggest that targeting SATB1 by itself will not be 
sufficient to treat breast cancer, but may require combination 
strategies of anti-SATB1 with gene targets such as UCA1.
MATERIALS AND METHODS
Detailed experimental procedures are described in Supple-
mentary Information.
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